Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cash Acquisitions

Adverum Biotechnlgs Cash Acquisitions Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cash Acquisitions from 2016 to 2016.
  • Adverum Biotechnlgs Cash Acquisitions for the quarter ending December 12, 2016 was $0m
  • Adverum Biotechnlgs Cash Acquisitions for the last 12 months ending September 09, 2017 was $0m a 0.00% decrease of -3m year over year
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Cash Acquisitions Data

12/2016$0m
09/2016$0m
06/2016$3m

Annual ADVM Cash Acquisitions Data

2016$3m